Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$51.4B |
| 2 |
Broadcom
AVGO
|
+$8.12B |
| 3 |
NVIDIA
NVDA
|
+$6.62B |
| 4 |
UnitedHealth
UNH
|
+$5.92B |
| 5 |
Apple
AAPL
|
+$5.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$14.9B |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.7B |
| 3 |
SNDK
Sandisk
SNDK
|
+$7.89B |
| 4 |
Netflix
NFLX
|
+$6.05B |
| 5 |
Coherent
COHR
|
+$4.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.62% |
| 2 | Industrials | 10.81% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 9.29% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Campbell Soup
CPB
$6.37B
| $11.4M | ﹤0.01% |
511,829
-410,927
| -45% | -$8.67M |
|
2002
Plumas Bancorp
PLBC
$438M
| $11.4M | ﹤0.01% |
194,999
-230,425
| -54% | -$12.2M |
|
|
CPRX
2003
DELISTED
Catalyst Pharmaceutical
CPRX
| $11.3M | ﹤0.01% |
360,468
+83,690
| +30% | +$2.47M |
|
2004
Nuveen ESG Small-Cap ETF
NUSC
$1.26B
| $11.3M | ﹤0.01% |
217,124
-3,122
| -1% | -$154K |
|
2005
NextNav
NN
$2.52B
| $11.3M | ﹤0.01% |
632,701
+520,880
| +466% | +$10.1M |
|
2006
Design Therapeutics
DSGN
$765M
| $11.2M | ﹤0.01% |
776,462
-21,949
| -3% | -$274K |
|
2007
FMC
FMC
$1.41B
| $11.2M | ﹤0.01% |
973,108
-102,688
| -10% | -$1.43M |
|
2008
KT
KT
$9.45B
| $11.2M | ﹤0.01% |
646,953
-83,716
| -11% | -$1.67M |
|
2009
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
| $11.2M | ﹤0.01% |
123,080
+5,490
| +5% | +$483K |
|
2010
Central Pacific Financial
CPF
$968M
| $11.1M | ﹤0.01% |
291,644
+25,042
| +9% | +$870K |
|
|
WSR
2011
DELISTED
Whitestone REIT
WSR
| $11.1M | ﹤0.01% |
587,118
+327,715
| +126% | +$6.16M |
|
|
PCG.PRX
2012
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.08B
| $11.1M | ﹤0.01% |
268,658
-29,400
| -10% | -$1.23M |
|
2013
KE Holdings
BEKE
$17.9B
| $11.1M | ﹤0.01% |
765,764
+342,396
| +81% | +$5.64M |
|
2014
Booz Allen Hamilton
BAH
$9.63B
| $11.1M | ﹤0.01% |
182,825
-407,602
| -69% | -$31.1M |
|
2015
McEwen Inc
MUX
$1.14B
| $11M | ﹤0.01% |
609,404
-147,634
| -20% | -$3.19M |
|
2016
Adient
ADNT
$1.42B
| $11M | ﹤0.01% |
600,861
+261,463
| +77% | +$5.59M |
|
2017
AMN Healthcare
AMN
$1.32B
| $10.9M | ﹤0.01% |
337,878
+42,023
| +14% | +$1.08M |
|
2018
Plug Power
PLUG
$2.86B
| $10.9M | ﹤0.01% |
4,017,359
-1,199,197
| -23% | -$3.77M |
|
2019
iShares MSCI ACWI ETF
ACWI
$32.7B
| $10.8M | ﹤0.01% |
69,100
+3,785
| +6% | +$578K |
|
2020
Vanguard FTSE Europe ETF
VGK
$30.1B
| $10.8M | ﹤0.01% |
122,459
+10,553
| +9% | +$924K |
|
2021
Kodiak Sciences
KOD
$2.07B
| $10.8M | ﹤0.01% |
276,984
+93,065
| +51% | +$3.62M |
|
2022
CarMax
KMX
$8.49B
| $10.7M | ﹤0.01% |
202,981
-260,210
| -56% | -$11.3M |
|
2023
Boston Beer
SAM
$1.76B
| $10.7M | ﹤0.01% |
60,625
-134,740
| -69% | -$27.3M |
|
2024
Hallador Energy
HNRG
$676M
| $10.7M | ﹤0.01% |
616,268
-27,850
| -4% | -$479K |
|
|
FBRX
2025
DELISTED
Forte Biosciences
FBRX
| $10.7M | ﹤0.01% |
502,826
+162,131
| +48% | +$3.84M |
|
Similar funds
Fidelity Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Fidelity Investments held 5,773 positions worth $2.3T, up 21% from $1.9T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fidelity Investments's Q2 2026 filing shows 351 new, 2,921 increased, 1,859 reduced and 211 closed positions. Its largest new stake was SpaceX: 302,555,831 shares worth $51.7B. The largest sale was Marvell Technology, an estimated $14.9B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Industrials and Communication Services.
- Fidelity Investments's largest Q2 2026 buy was SpaceX: 302,555,831 shares worth $51.7B.
- Fidelity Investments added most to Broadcom in Q2 2026, an estimated $8.12B increase.
- Fidelity Investments's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $14.9B.
- Fidelity Investments fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $272M.
- Fidelity Investments's ten largest holdings make up 34% of its $2.3T portfolio in Q2 2026.
- Fidelity Investments opened 351 new positions and closed 211 in Q2 2026.
- Fidelity Investments's portfolio value rose 21% quarter-over-quarter to $2.3T.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.